Further evidence for amyloid deposition in clinical pancreatic islet grafts. - Wikidata - wikimedia - TriplyDB

Further evidence for amyloid deposition in clinical pancreatic islet grafts.

Further evidence for amyloid deposition in clinical pancreatic islet grafts.

http://www.wikidata.org/entity/Q41623363

about

Recovery of endocrine function after islet and pancreas transplantation Total pancreatectomy with islet autotransplantation: summary of a National Institute of Diabetes and Digestive and Kidney diseases workshop.Total pancreatectomy with islet autotransplantation: summary of an NIDDK workshop.Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology.Matrix Metalloproteinase-9 Protects Islets from Amyloid-induced Toxicity Oxygenation of the Intraportally Transplanted Pancreatic Islet.Clinical pancreatic islet transplantation.Eighty years of research on islet amyloidosis in Uppsala.Rosiglitazone treatment does not decrease amyloid deposition in transplanted islets from transgenic mice expressing human islet amyloid polypeptide.Transplantation of Macro-encapsulated Human Islets within the Bioartificial Pancreas β Air to Patients with Type 1 Diabetes Mellitus.Loss of end-differentiated β-cell phenotype following pancreatic islet transplantation.Extensive amyloid formation in transplanted microencapsulated mouse and human islets.Anakinra Protects Against Serum Deprivation-Induced Inflammation and Functional Derangement in Islets Isolated From Nonhuman Primates.Islet Amyloid in Whole Pancreas Transplants for Type 1 Diabetes Mellitus (DM): Possible Role of Type 2 DM for Graft Failure.The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: implications in type 2 diabetes and islet transplantation.Use of the PET ligand florbetapir for in vivo imaging of pancreatic islet amyloid deposits in hIAPP transgenic mice

P2860

Q26822596-613276EE-F46E-4167-93FA-F8A9D7436784 Q34383031-DFD75E94-497B-4C96-9D25-333F2A4C3C96 Q36054574-F63F78F9-1E5D-4D21-AF5E-5B07F86C3C79 Q36327915-C15329B1-570C-4AC7-9BE0-C8F4633B2A71 Q36381947-5F3CC9B5-3F12-42A7-B026-D7C95EFEEE25 Q37410835-CABC0833-23F6-47AA-B817-08BFBD7537CD Q39005220-923B170B-B139-4490-861D-F6736E4BF7D7 Q41845860-2594374C-888B-4132-BC5F-0F2DC2E32C1A Q43224961-BB066FDB-CF7D-42F8-BF26-26FDA9A63970 Q47210419-6051AA0B-0F70-48F6-8A96-A49B8ADFAE4E Q49832092-C0FB2E2E-D2D8-4498-8F39-1B361B91B0C1 Q50510994-E312BDD6-035C-4C7D-AC70-E7EE62940AC2 Q51269375-20BF1F54-BD64-443F-B72E-42FF64112AA4 Q53523992-B470FC95-9168-47F4-9631-25D457CD6BBB Q54463919-BA5CF40C-DFE2-44C5-9FE1-C632EB9647EC Q57137026-4B1CD620-432D-484F-A0CA-545F086CD222

P2860

Further evidence for amyloid deposition in clinical pancreatic islet grafts.

http://www.wikidata.org/entity/Q41623363

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Further evidence for amyloid deposition in clinical pancreatic islet grafts.

@en

type

label

Further evidence for amyloid deposition in clinical pancreatic islet grafts.

@en

prefLabel

Further evidence for amyloid deposition in clinical pancreatic islet grafts.

@en

P1433

Q41623363-2642DD4E-618B-4116-9505-970BE0EBC414

P1476

Q41623363-AEA39F62-4A39-46CE-ADC1-6125493C2842

P2093

Q41623363-28F7C78A-0AD2-44B2-A4C3-93BA36AC5F57

Q41623363-3399969E-AE2C-45A1-87CA-67620055E643

Q41623363-5586D8D9-9670-437A-801E-CB997849442D

Q41623363-693183CF-C015-4A37-98DE-8FEC330E8216

Q41623363-90DFE430-6B4A-450A-8A9F-C22164212091

Q41623363-D2433BD5-FA32-4301-A011-94D021B3C097

Q41623363-DD01A38C-A703-47D4-8D4E-F5AD04B56179

Q41623363-F758506B-BB32-4DA8-9FAA-848117FB51F0

Q41623363-F90EF378-51F3-4020-B79C-BDE854981456

Q41623363-FC1CDA9D-6A92-459C-86F3-640E1A4AB895

P2860

Q41623363-0AAD2912-41C0-40E4-A717-CE04EC3C1F12

Q41623363-15782A54-68A5-455C-87DF-33CDD9C5615E

Q41623363-169B4E43-FC9E-477E-BE9D-EDD66300CCC3

Q41623363-1FE4DD5A-9643-49C9-A830-14C6A7F017E7

Q41623363-59A9FEBB-2D0A-488F-8768-0CD2152D6C6C

Q41623363-6CA01DE9-B92C-4C04-9C79-47E7CED40D1A

Q41623363-7786D97E-5507-4022-A569-7837258CA22E

Q41623363-7FDF1BEC-3D17-4403-A6A4-E2E462F714AB

Q41623363-8667D9D8-2CB6-4A82-9744-146545A87E53

Q41623363-8CF64D16-BB5C-41E7-BF08-4FA5B2AECB08

P304

Q41623363-C7F7E307-4A97-46EE-8C15-278935588C92

P31

Q41623363-0196C80C-9AAC-48C2-BDF1-ADE3478A38B4

P356

Q41623363-E2C5FA90-D134-4900-9B67-1CA53B6AC8E8

P433

Q41623363-48BFEF4A-F3F3-4D41-892F-93B90CDFA6E6

P478

Q41623363-A305EBF0-6FC8-400D-B17F-5066A52E214E

P50

Q41623363-82830FED-4BB9-4EEC-9C95-361925FF9651

P577

Q41623363-C050C66D-F7B7-4E5C-A587-B870DBD14EC9

P5875

Q41623363-C47AE3D5-CF55-4965-9612-59B628094C6A

P698

Q41623363-36A5A0BD-49A2-47F5-8BB0-C2869E568637

P932

Q41623363-175AE871-41A9-4703-ACBA-B70BD1C8E3FC

P356

TP.0B013E31823E46EF

P1433

Transplantation

P1476

Further evidence for amyloid deposition in clinical pancreatic islet grafts.

@en

P2093

A M James Shapiro

http://www.w3.org/2001/XMLSchema#string

Alberto M Davalli

http://www.w3.org/2001/XMLSchema#string

Antonio Secchi

http://www.w3.org/2001/XMLSchema#string

Arne Andersson

http://www.w3.org/2001/XMLSchema#string

Christian Toso

http://www.w3.org/2001/XMLSchema#string

Franco Folli

http://www.w3.org/2001/XMLSchema#string

Gunilla T Westermark

http://www.w3.org/2001/XMLSchema#string

Gunnar Tufveson

http://www.w3.org/2001/XMLSchema#string

Per Westermark

http://www.w3.org/2001/XMLSchema#string

Tatsuya Kin

http://www.w3.org/2001/XMLSchema#string

P2860

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation

Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts.

Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets.

Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.

Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in beta-cell death in type 2 diabetes mellitus

Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons.

Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.

Influence of microenvironment on engraftment of transplanted β-cells.

Amyloid in the islets of Langerhans: thoughts and some historical aspects.

P304

219-223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TP.0B013E31823E46EF

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51919284

http://www.w3.org/2001/XMLSchema#string

P698

22193043

http://www.w3.org/2001/XMLSchema#string

P932

5587891

http://www.w3.org/2001/XMLSchema#string